Hypoglycemia and propranolol in pediatric behavioral disorders.
Chavez
H
H
Department of Pediatric Emergency Medicine, Children's Hospital, St Paul, MN 55102, USA.
Ozolins
D
D
Losek
J D
JD
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D015600:Glasgow Coma Scale; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D011433:Propranolol / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D011433:Propranolol